Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus

Published:2011-12-29 Issue:12 Volume:6 Page:e29778
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hoopes Justin D.,Driebe Elizabeth M.,Kelley Erin,Engelthaler David M.,Keim Paul S.,Perelson Alan S.,Rong Libin,Went Gregory T.,Nguyen Jack T.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.;MA Thompson;JAMA,2010

2. Confronting the emergence of drug-resistant HIV type 1: impact of antiretroviral therapy on individual and population resistance.;ES Daar;AIDS Res Hum Retroviruses,2005

3. The survival benefits of AIDS treatment in the United States.;RP Walensky;J Infect Dis,2006

4. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.;RM Gulick;N Engl J Med,1997

5. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.;SM Hammer;N Engl J Med,1997

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An orally active entry inhibitor of influenza A viruses protects mice and synergizes with oseltamivir and baloxavir marboxil;Science Advances;2024-02-23

2. Application of Cryoelectron Microscopy in Antiviral Research;Livestock Diseases and Management;2024

3. Influenza Treatment: Limitations of Antiviral Therapy and Advantages of Drug Combination Therapy;Microorganisms;2023-01-11

4. Antiviral Potential of Natural Resources against Influenza Virus Infections;Viruses;2022-11-05

5. Nanotechnology: New frontiers in anti-HIV therapy;Nanotechnological Applications in Virology;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3